SCLERODERMA (BASED ON A STUDY OF OVER 150 CASES)
Authors: I LEINWAND, A W DURYEE, M N RICHTER
Journal: Annals of Internal Medicine (1954)

Article1 November 1954SCLERODERMA (BASED ON A STUDY OF OVER 150 CASES)IRVING LEINWAND, M.D., A. WILBUR DURYEE, M.D., F.A.C.P., MAURICE N. RICHTER, M.D.IRVING LEINWAND, M.D., A. WILBUR DURYEE, M.D., F.A.C.P., MAURICE N. RICHTER, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-41-5-1003 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptScleroderma is not a common disease, nor is it rare. The first description of this condition is credited to Curzio1of Naples in 1752. Since that time there have been hundreds of cases described. It has often been reported in association with dermatomyositis, which it closely resembles.2-8Scleroderma was first regarded as primarily a skin disease. Any systemic complaints for the most part received scant attention, since the skin lesions far overshadowed other symptoms. In reviewing the history of scleroderma one is impressed by the metamorphosis of opinion regarding the classification of this disease.9, 10This is due mainly to...Bibliography1. Curzio : Dissertations anatomique et pratique sur une maladie de la peau d'une espece fort rare et fort singuliere, No. 23, 1752. Google Scholar2. Griffiths WJ: Biochemical aspects of dermatomyositis, Brit. J. Dermat. 52: 295, 1940. CrossrefGoogle Scholar3. Freudenthal W: Generalized scleroderma and dermatomyositis: a histological comparison, Brit. J. Dermat. 52: 289, 1940. CrossrefGoogle Scholar4. Lewis T: Notes on scleroderma (dermatomyositis), Brit. J. Dermat. 52: 233, 1940. CrossrefGoogle Scholar5. Dowling GB: Generalized scleroderma, Brit. J. Dermat. 52: 333, 1940. CrossrefGoogle Scholar6. DowlingGriffiths GBWJ: Dermatomyositis and progressive scleroderma, Lancet 1: 1424, 1939. CrossrefGoogle Scholar7. TalbotGallConsolazioCoombs JHEAWVFS: Dermatomyositis with scleroderma, calcinosis and renal endarteritis associated with focal cortical necrosis, Arch. Int. Med. 63: 476, 1939. CrossrefGoogle Scholar8. Banks BM: Is there a common denominator in scleroderma, dermatomyositis, disseminated lupus erythematosis, the Libman-Sacks syndrome and polyarteritis nodosa? New England J. Med. 225: 433, 1941. CrossrefGoogle Scholar9. Boardman WP: Scleroderma, with special reference to its etiology and treatment, Arch. Dermat. and Syph. 19: 901, 1929. CrossrefGoogle Scholar10. Burch GE: Scleroderma: Etiology and abnormal physiology, New Orleans M. and S. J. 92: 12, 1939. Google Scholar11. O'LearyNomland PAR: A clinical study of one hundred and three cases of scleroderma, Am. J. M. Sc. 180: 95, 1930. CrossrefGoogle Scholar12. LericheJung RA: Recherche sur la nature de la sclerodermie. Les traductions tissulaires de l'hyperparathyroidism dans la sclerodermie, Presse méd. 43: 1361, 1935. Google Scholar13. LericheJungDeBakey RAMM: The surgical treatment of scleroderma. Rationale of sympathectomy and parathyroidectomy, Surgery 1: 6, 1937. Google Scholar14. LericheJungSureyya RAC: La peau dans l'hyperparathyroidism experimental, etude de la sclerodermie experimentale, Presse méd. 43: 777, 1935. Google Scholar15. BernheimGarlock ARJH: Parathyroidectomy for Raynaud's disease and scleroderma, Ann. Surg. 101: 1012, 1935. CrossrefMedlineGoogle Scholar16. Garlock JH: Parathyroidectomy for Raynaud's disease and scleroderma, S. Clin. North America 16: 771, 1936. Google Scholar17. BernheimGarlock ARJH: Parathyroidectomy for Raynaud's disease and scleroderma (late results), Arch. Surg. 38: 543, 1939. CrossrefGoogle Scholar18. OchsnerDeBakey AM: Surgical considerations of scleroderma, New Orleans M. and S. J. 92: 24, 1939. Google Scholar19. CornbleetStruck THC: Calcium metabolism in scleroderma, Arch. Dermat. and Syph. 35: 188, 1937. CrossrefGoogle Scholar20. Selye H: A condition simulating human scleroderma in rats injected with parathyroid hormone, J. A. M. A. 99: 108, 1932. CrossrefGoogle Scholar21. PerezSofferSilbert WMLSS: Improvement in two cases of diffuse scleroderma by the use of Dihydrotachysterol (A.T. 10), J. Mt. Sinai Hosp. 6: 333, 1940. Google Scholar22. AdsonO'LearyBrown AWPAGE: Surgical treatment of vasospastic types of scleroderma by the resection of sympathetic ganglia and trunks, Ann. Int. Med. 4: 555, 1930. LinkGoogle Scholar23. McCracken RH: Scleroderma. Report of a case with scleroderma and hemiatrophy, J. Pediat. 9: 173, 1936. Google Scholar24. Steven JL: Case of scleroderma with pronounced hemiatrophy of the face, body and extremities—death from ovarian tumor—account of the postmortem examination: a sequel, Glasgow M. J. 50: 401, 1898. MedlineGoogle Scholar25. PetraceckPitka EV: Unilateral scleroderma with signs of cerebral lesion, Ceska derm. 17: 251, 1937. Google Scholar26. Murray-Will E: Scleroderma and syphilis, Brit. J. Dermat. 9: 187, 1924. Google Scholar27. Moench LM: A case of chronic arsenic poisoning in a child associated with profound anemia and scleroderma, New York State J. Med. 36: 1029, 1936. Google Scholar28. Ayres S: Scleroderma as a possible manifestation of chronic arsenic poisoning, Arch. Dermat. and Syph. 2: 747, 1920. CrossrefGoogle Scholar29. DuryeeWright AWIS: The treatment of scleroderma by means of acetyl beta methyl chloride (Mecholyl) iontophoresis, Am. Heart J. 14: 603, 1937. CrossrefGoogle Scholar30. LewisLandis TEM: Further observations upon a variety of Raynaud's disease with special reference to arteriolar defects and to scleroderma, Heart 15: 330, 1929-31. Google Scholar31. BrownO'Leary GEPA: Skin capillaries in scleroderma, Arch. Int. Med. 36: 73, 1925. CrossrefGoogle Scholar32. MasugiYa MS: Diffuse scleroderma and its vascular changes, Virchows Arch. f. path. Anat. 302: 39, 1938. CrossrefGoogle Scholar33. Weidman FD: Necropsy findings in a case of congenital scleroderma and sclerodactylia, Arch. Dermat. and Syph. 1: 375, 1920. CrossrefGoogle Scholar34. Osler W: On diffuse scleroderma with special reference to diagnosis and to the use of thyroid gland extract, J. Cut. and Genito-urinary Dis. 16: 127, 1898. Google Scholar35. WrightLilienfeldMacLanathen ISAE: Determination of vitamin C saturation, Arch. Int. Med. 60: 264, 1937. CrossrefGoogle Scholar36. Clinicopathological Conferences New York Post-Graduate Hospital: Case report, New York State J. Med. 41: 1870, 1941. Google Scholar37. O'LearyWaisman PAM: Acrosclerosis, Proc. Staff Meet., Mayo Clin. 15: 702, 1940. Google Scholar38. HollanderVogel LHR: Acrosclerosis, Pennsylvania M. J. 43: 1089, 1940. Google Scholar39. Puddu V: Un caso de sclerodermia con calcificazioni, Policlinico (sez. prat.) 41: 1801, 1934. Google Scholar40. Weber H: Korresp. Bl. schwiz. Ärz. 8: 623, 1878. Google Scholar41. Hutchinson J: Acro-scleroderma following Raynaud's phenomena, Clin. J. 7: 240, 1896. Google Scholar42. KlempererPollackBaehr PADG: Pathology of disseminated lupus erythematosis, Arch. Path. 32: 569, 1941. Google Scholar43. KlempererPollackBaehr PADG: Diffuse collagen disease: acute disseminated lupus erythematosus and diffuse scleroderma, J. A. M. A. 119: 331, 1942. CrossrefGoogle Scholar44. Weiss S: Diseases associated with inflammatory lesions of the peripheral arteries, New England J. Med. 225: 579, 1941. CrossrefGoogle Scholar45. Prinzmetal M: Mechanism of circulatory insufficiency in Raynaud's disease in association with sclerodactylia, Arch. Int. Med. 58: 309, 1936. CrossrefGoogle Scholar46. Johnson CA: A study of the clinical manifestations and the results of treatment of twenty-two patients with Raynaud's symptoms, Surg., Gynec. and Obst. 72: 889, 1941. Google Scholar47. EdwardsHamiltonDuntleyHubert EAJBSQG: Cutaneous vascular changes and pigmentary changes in castrate and eunuchoid men, Endocrinology 28: 119, 1941. CrossrefGoogle Scholar48. TurnerLackamnHellbaum HHEAA: Effect of testosterone propionate on bone growth and skeletal maturation of normal and castrated male rats, Endocrinology 29: 425, 1941. CrossrefGoogle Scholar49. DayFollis HGRH: Skeletal changes in rats receiving estradiol benzoate as indicated by histological studies and determinations of bone ash, serum calcium, and phosphatase, Endocrinology 28: 83, 1941. CrossrefGoogle Scholar50. WentworthSmithGardner JHPKWV: Composition of bones of mice receiving estrogens and androgens, Endocrinology 26: 61, 1940. CrossrefGoogle Scholar51. Barlow GB: Scleroderma associated with adrenal neoplasm, Arch. Dermat. and Syph. 39: 1021, 1939. CrossrefGoogle Scholar52. PacellaBarrera BLSE: Electroencephalography: its applications in neurology and psychiatry, Psychiatric Quart. 15: 407, 1941. CrossrefGoogle Scholar53. MurphyKraininGerson JRPMJ: Scleroderma with pulmonary fibrosis, J. A. M. A. 116: 499, 1941. CrossrefGoogle Scholar54. LinenthalTalkov HR: Pulmonary fibrosis in Raynaud's disease, New England J. Med. 224: 682, 1941. CrossrefGoogle Scholar55. Getzowa S: Cystic and compact pulmonary sclerosis in progressive scleroderma, Arch. Path. 40: 99, 1945. Google Scholar56. BaehrPollack GA: Diffuse vascular diseases, Mod. Concepts Cardiovas. Dis. 15: (Dec.) 1946. MedlineGoogle Scholar57. PughKvaleMargulis DWFH: Scleroderma with involvement of the viscera: report of a case, Proc. Staff Meet., Mayo Clin. 20: 410, 1945. Google Scholar58. LindsayTempletonRothman JFS: Lesions of the esophagus in generalized progressive scleroderma, J. A. M. A. 123: 745, 1943. CrossrefGoogle Scholar59. Jackman J: Roentgen features of scleroderma and acrosclerosis, Radiology 40: 163, 1943. CrossrefGoogle Scholar60. HaleSchatzki CR: The roentgenological appearance of the gastrointestinal tract in scleroderma, Am. J. Roentgenol. 11: 407-420, 1944. Google Scholar61. Guttmacher A: A case of severe scleroderma with successful delivery, Urol. and Cutan. Rev. 107: 108, 1943. Google Scholar62. ByronMichalover CS: Calcinosis and scleroderma with parathyroidectomy, Ann. Int. Med. 18: 2, 1943. Google Scholar63. RafskyHerzig HW: Scleroderma with oesophageal symptoms, Gastroenterology 6: 1, 1946. MedlineGoogle Scholar64. BerchowPoppel CM: Interstitial calcinosis circumscripta associated with scleroderma and Raynaud's disease, Radiology 39: 96, 1942. CrossrefGoogle Scholar65. OlsenO'LearyKirklin APB: Esophageal lesions associated with acrosclerosis and scleroderma, Arch. Int. Med. 76: 189, 1945. CrossrefGoogle Scholar66. Goetz RH: The pathology of progressive systemic sclerosis (generalized scleroderma), Clin. Proc. 4: 337-392, 1945. Google Scholar67. Graham TN: Metabolic cutaneous calcinosis, Arch. Dermat. and Syph. 41: 864, 1940. CrossrefGoogle Scholar68. MathisonPalmer AKJD: Diffuse scleroderma with involvement of the heart; report of a case, Am. Heart J. 33: 366, 1947. CrossrefMedlineGoogle Scholar69. HerstoneBrower SJ: Werner syndrome, Am. J. Roentgenol. 51: 639, 1944. Google Scholar70. Bevans M: Pathology with special reference to changes in the G.I. tract, Am. J. Path. 21: 25, 1945. MedlineGoogle Scholar71. Leriche R: Sympathectomy for severe generalized scleroderma, complete case maintained for 7 years, Lyon chir. 37: 79, 1941, 1942. Google Scholar72. WeissSteadWarrenBailey SEAJVDT: Scleroderma heart disease, Arch. Int. Med. 71: 749, 1943. CrossrefGoogle Scholar73. Thomas EW: Thibierge-Weissenbach syndrome, calcinosis cutis and scleroderma, Lancet 2: 389, 1942. CrossrefGoogle Scholar74. Bauer J: Progressive facial hematrophy; disseminated scleroderma and muscular cramps, Confinia neurol. 7: 3, 1946. CrossrefMedlineGoogle Scholar75. LewinHeller GJ: Die Sclerodermie, 1895, A. Hirschwald, Berlin. Google Scholar76. ThibiergeWeissenbach GA: Concretions calcaires sous-cutanées et sclérodermie, Ann. de dermat. et syph. 3: 129, 1911. Google Scholar77. WeberScholefield FPRE: Case of sclerodactylia with subcutaneous calcareous concretion, Brit. J. Dermat. 23: 276, 1911. CrossrefGoogle Scholar78. Durham RH: Scleroderma and calcinosis, Arch. Int. Med. 42: 467, 1928. CrossrefGoogle Scholar79. BrodyBellin JDE: Calcinosis with scleroderma, Arch. Dermat. and Syph. 36: 85, 1937. CrossrefGoogle Scholar80. BauerMarbleBennett WAGA: Further studies in a case of calcification of subcutaneous tissue in a child, Am. J. M. Sc. 182: 237, 1931. CrossrefGoogle Scholar81. Bolam M: Calcinosis with a report of a case of calcinosis universalis, Brit. J. Dermat. 47: 340, 1935. CrossrefGoogle Scholar82. Wells HG: Chemical pathology, 5th Ed., 1925, W. B. Saunders Co. Philadelphia, p. 493. Google Scholar83. Norman CF: Vitamin D therapy in the treatment of scleroderma and allied conditions; three cases, Geriatrics 2: 24, 1943. Google Scholar84. von Notthafft A: Neuere Arbeiten ueber Sklerodermie, Centralbl. f. allg. Path. u. path. Anat. 9: 870, 1898. Google Scholar85. Matsui S: Ueber die Pathologie and Pathogenese von Sklerodermie universalis, Mitt. a. d. med. Fak. d. k. Univ. zu Tokyo 31: 55, 1924. Google Scholar86. Kraus EJ: Zur Pathogenese der diffusen Skerodermie, Virchows Arch. f. path. Anat. 253: 710, 1924. CrossrefGoogle Scholar87. Sellei J: Die Akrosklerosis Sklerodaktylie und deren Symptomenkomplex nebst neueren Untersuchungen bei Sklerodermie, Arch. f. Dermat. and Syph. 47: 382, 1931. Google Scholar88. Rake G: On the pathology and pathogenesis of scleroderma, Bull. Johns Hopkins Hosp. 48: 212, 1931. Google Scholar89. MacCallum WG: Acute diffuse scleroderma, Tr. A. Am. Physicians 41: 190, 1926. Google Scholar90. Ehrman S: Ueber die Beziehung der Sklerodermie zu den autotoxischen Erythamen, Wien. med. Wchnschr. 53: 1097, 1903. Google Scholar91. FesslerPohl AR: Stenosierender Prozess des Oesophagus bei Sklerodermie, Dermat. Ztschr. 63: 164, 1932. CrossrefGoogle Scholar92. KureYamagataTsukadaHiyoshi KLSJ: Passagestörung des Oesophagus bei Sklerodermie und Dystrophia musculorum progressiva, Klin. Wchnschr. 51: 477, 1936. Google Scholar93. GoetzRous RHMC: Note on case showing Raynaud's phenomenon and additional manifestations, Clin. Proc. 1: 244, 1942. Google Scholar94. Dostrovsky A: Progressive scleroderma of the skin with cystic sclerodermal changes of the lungs, Arch. Dermat. and Syph. 55: 1, 1947. CrossrefGoogle Scholar95. Podkaminsky NA: Acrosclerosis hyperplastica intraossa, Am. J. Roentgenol. 38: 889, 1937. Google Scholar96. Finlay DW: Scleroderma, Middlesex Hosp. Rep. (1889) p. 29, cited by Luithelin f. in Mracek, F.: Handbuch der Hautkrankheiten, Vienna, A. Holder, 3: 152, 1904. Google Scholar97. WalkerBenditt SAEP: An electrophoretic study of the serum proteins in scleroderma, Proc. Soc. Exper. Biol. and Med. 67: 504, 1948. CrossrefMedlineGoogle Scholar98. EastOram TS: The heart in scleroderma, Brit. Heart J. 9: 3, 1947. CrossrefGoogle Scholar99. Wuerthele-CaspeBrodkinMermod VEC: Etiology of scleroderma, J. M. Soc. New Jersey 44: 256, 1947. MedlineGoogle Scholar100. Jadassohn J: Arch. f. Dermat. u. Syph. 126: 172, 1919, quoted by Cornbleet and Struck.19 Google Scholar101. AgatstonGartner SAS: Precocious cataracts and scleroderma, Arch. Ophth. 21: 492, 1939. CrossrefGoogle Scholar102. StafneAustin ECLT: Characteristic dental findings in acrosclerosis and diffuse scleroderma, Am. J. Orthodontics (Oral Surg. Sect.) 30: 25, 1944. CrossrefGoogle Scholar103. Rosenthal IH: Generalized scleroderma hidebound disease its relation to the oral cavity with case history and dental restoration, Oral Surg., Oral Med. and Oral Path. 1: 1019, 1948. CrossrefMedlineGoogle Scholar104. Duryee AW: Scleroderma, Trans. Am. Ther. Soc. 42: 127, 1942. Google Scholar105. Leinwand I: Lipid and protein fractions. (3) Diseases of the mesenchyme, J. Lab. and Clin. Med. 37: 532, 1951. MedlineGoogle Scholar106. KobatHangarMooreLandow EAFMDHH: The relation of the cephalin flocculation and colloidal gold reactions to the serum proteins, J. Clin. Investigation 22: 563, 1943. CrossrefMedlineGoogle Scholar107. MooreSheehan HCHL: The kidney of scleroderma, Lancet 1: 68, 1952. CrossrefMedlineGoogle Scholar108. EvansRubitskyPerry JAHJAW: Treatment of diffuse progressive scleroderma, J. A. M. A. 151: 891, 1953. MedlineGoogle Scholar109. Clinico-Pathologic Conference: Scleroderma with congestive heart failure, Am. J. Med. 14: 231, 1953. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Received for publication November 23, 1953.From the Departments of Medicine and Pathology, New York University Post-Graduate Medical School and the University Hospital, New York, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySystemic sclerosis and urinary symptoms: a complex pathophysiologyAfrican Americans and Scleroderma: Examining the Root Cause of the AssociationPrevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter StudyThe limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre studyOverlooked ManifestationsNephrosclerosis and HypertensionConnective tissue disordersTo Spare or Not to Spare…? The Aortic Valve in Scleroderma and Aortic Root AneurysmNeurologic involvement in scleroderma: A systematic reviewRace and Association With Disease Manifestations and Mortality in SclerodermaVascular DiseasesScleroderma: The Need for Extreme RemediesSystemic sclerosis is an independent risk factor for increased coronary artery calcium depositionIntracranial Aneurysms in Patients With CREST Syndrome -Two Case Reports-The Heart in SclerodermaConnective Tissue Diseases and the HeartEnfermedades vascularesAssociation of an irregularly shaped anterior choroidal aneurysm with CREST syndromeSystemic SclerosisAtteinte vésicale dans la sclérodermie : à propos de 3 casPeripheral neuropathy in sclerodermaCardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: An endomyocardial biopsy studySclérodermie systémique et grossesseEvidence of cerebral hypoperfusion in scleroderma patientsBesondere Erkrankungen der GallenblaseFertility and pregnancy outcome in women with systemic sclerosisImpaired quantitative cerebral blood flow in scleroderma patientsNeurologic Abnormalities in Two Patients with Facial Hemiatrophy and Sclerosis Coexisting with MorpheaA Case of Melanoma Concurrent with Progressive Systemic SclerosisRelationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma)CARDIAC INVOLVEMENT IN SCLERODERMATHE NERVOUS SYSTEM IN SYSTEMIC SCLEROSIS (SCLERODERMA)Depressive symptoms associated with sclerodermaVesical Dysfunction in Systemic Sclerosis (Scleroderma)Systemic sclerosis terminating as systemic necrotizing angiitisCancer in systemic sclerosisManagement of autoimmune disordersSystemic sclerosis in the elderlyNon-invasive evaluation of long-term cardiac effects of captopril in systemic sclerosisScleroderma 'en coup de sabre'.Scleroderma and central nervous system vasculitis.Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two casesPregnancy in women with systemic sclerosisSkin diseases aggravated by pregnancyProgressive systemic sclerosis: Mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patientsSjögren's Syndrome and Systemic Sclerosis (Scleroderma)Zirkumskripte Sklerodermie — eine Systemkrankheit?Peripheral neuropathy in course of progressive systemic sclerosisThe cardiovascular manifestations of systemic sclerosis (scleroderma)The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literaturePrediction of survival in progressive systemic sclerosis by multivariate analysis of clinical featuresPregnancy and systemic sclerosisPhysiologic Abnormalities of Cardiac Function in Progressive Systemic Sclerosis with Diffuse SclerodermaProgressive Systemic SclerosisProgressive systemische Sklerodermie (Sklerose)Scleroderma and erosive polyarthritis: a disease entity?Arterial Occlusive Diseases of the Upper ExtremityPresence of eosinophilia in progressive systemic sclerosis and localized sclerodermaThe arthropathy of advanced progressive systemic sclerosisAssociation of myositis and myocarditis in progressive systemic sclerosisRaynaud syndromeThe Prevalence of Conduction Defects and Cardiac Arrhythmias in Progressive Systemic SclerosisNIGEL K. ROBERTS, M.D., WILLIAM R. CABEEN Jr., M.D., JUDITH MOSS, R.N., PHILIP J. CLEMENTS, M.D., DANIEL E. FURST, M.D.Classification and Nomenclature of Progressive Systemic Sclerosis (Scleroderma)Progressive Systemic Sclerosis: Cardiac InvolvementProgressive Systemic Sclerosis: Kidney InvolvementPart III: Immunosuppressive AgentsThe Kidney in Progressive Systemic Sclerosis A Prospective StudyMICHAEL T. KOVALCHIK, M.D., STEPHEN J. GUGGENHEIM, M.D., MICHAEL H. SILVERMAN, M.D., JAMES S. ROBERTSON, M.D., JAMES C. STEIGERWALD, M.D.Successful Medical Treatment of Scleroderma Renal CrisisProgressive systemic sclerosisProgressive systemic sclerosis with eosinophilia and a fulminating courseSklerodermieSjögren's Syndrome in Progressive Systemic SclerosisJAMES F. CIPOLETTI, M.D., ROBERT B. BUCKINGHAM, M.D., F.A.C.P., E. LEON BARNES, M.D., ROBERT L. PEEL, M.D., KHALID MAHMOOD, M.D., FRANKLIN E. CIGNETTI, M.D., JOHN M. PIERCE, M.D., BRUCE S. RABIN, M.D., GERALD P. RODNAN, M.D., F.A.C.P.Scleroderma of lower urinary tractInfluence of Cold On Catecholamine Response of Vascular Smooth Muscle Strips From Resistance Vessels of Scleroderma SkinMyocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.Scleroderma in the childScleroderma in childhood: Report of 5 casesPericardial disease in scleroderma (systemic sclerosis)Stercoral ulceration and perforation of the sclerodermatous colonMotor Disorders Due to Collagen DiseasesScleroderma (progressive systemic sclerosis) inducing ureteral closureIntroductionSekundäre maligne Tumoren der Bronchien und LungenREFERENCESGENERALIZED SCLERODERMASurvival with Systemic Sclerosis (Scleroderma) A Life-Table Analysis of Clinical and Demographic Factors in 309 PatientsTHOMAS A. MEDSGER JR., M.D., ALFONSE T. MASI, M.D., Dr. P.H., F.A.C.P., GERALD P. RODNAN, M.D., F.A.C.P., THOMAS G. BENEDEK, M.D., F.A.C.P., HARRY ROBINSON, D.Sc.Epidemiology of Systemic Sclerosis (Scleroderma)THOMAS A. MEDSGER JR., M.D., ALFONSE T. MASI, M.D., Dr. P.H., F.A.C.P.IMMUNOLOGICAL ASPECTS OF SYSTEMIC SCLEROSIS: IN VITRO ACTIVITY OF LYMPHOCYTES FROM PATIENTS WITH THE DISORDERSurgical treatment of strictures of the esophagus in patients with sclerodermaSCLERODERMA IN THE ELDERLY, WITH SPECIAL REFERENCE TO THE CRST SYNDROMEOesophagusVascular Disease in Progressive Systemic Sclerosis (Scleroderma)WALTER L. NORTON, M.D., F.A.C.P., JOHN M. NARDO, M.D.The esophagus in progressive systemic sclerosisNephrosclerosis and HypertensionAutoimmune Conditions During PregnancyPathologic observations in systemic sclerosis (scleroderma)OesophagusPericardial and myocardial disease in progressive systemic sclerosisScleroderma and pregnancyDie pathologische Anatomie der intern-medizinisch bedeutsamsten NierenkrankheitenProgressive systemic sclerosis: I. Gastric secretory patternProgressive systemic sclerosis: II. Esophageal involvementEpidemiology of Fatal Systemic Sclerosis (Diffuse Scleroderma) A 15-Year Survey in BaltimoreALFONSE T. MASI, M.D., DR.P.H., F.A.C.P., WILLIAM A. D'ANGELO, M.D.The Association of Progressive Systemic Sclerosis (Scleroderma) with Coal Miners' Pneumoconiosis and Other Forms of SilicosisGERALD P. RODNAN, M.D., F.A.C.P., THOMAS G. BENEDEK, M.D., THOMAS A. MEDSGER JR., M.D., ROY J. CAMMARATA, M.D.Hyperplasia of the thymus in progressive systemic sclerosisHautveränderungen bei inneren ErkrankungenNeurologische und elektrophysiologische Untersuchungen bei progressiver Sklerodermie und Morphaea�ber Glask�rperver�nderungen bei SklerodermieAnkylosing spondylitis with widespread arteritisAnalysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literatureOesophageal changes in systemic sclerosis.The heart in sclerodermaScleroderma in childhoodEntwicklungslinien der Sklerodermieforschung in der GegenwartTHE RADIOLOGICAL MANIFESTATIONS OF SCLERODERMA (DIFFUSE SYSTEMIC SCLEROSIS)ELECTRON MICROSCOPIC OBSERVATIONS ON SKELETAL MUSCLE IN DIFFUSE SCLERODERMA.Case 51-1965DermatomyositisAn early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma)"Acquired" antibody hemolytic anemia and familial aberrations in gamma globulinsCollagen Diseases and the Nervous SystemDermatomyositis and Focal SclerodermaPulmonary Vascular Lesions in Systemic SclerodermaScleroderma of the Esophagus A Correlation of Histologic and Physiologic FindingsWILLIAM L. TREACY, M.D., ARCHIE H. BAGGENSTOSS, M.D., CHARLES H. SLOCUMB, M.D., CHARLES F. CODE, M.D.A review of recent observations and current theories on the etiology and pathogenesis of progressive systemic sclerosis (diffuse scleroderma)Neuromuscular disorders associated with malignant neoplastic diseaseUlceration and Perforation of the Intestine Due to Necrotizing ArteriolitisScleroderma and its oral manifestationsFunctional and morphologic alterations of the gastrointestinal tract in progressive systemic sclerosis (scleroderma)Digestive System Manifestations of the Collagen DiseasesDiffuse Systemic Scleroderma A Comparison with AcrosclerosisDENNY L. TUFFANELLI, M.D., R. K. WINKELMANN, M.D.An Historical Account of the Study of Progressive Systemic Sclerosis (Diffuse Scleroderma)GERALD P. RODNAN, M.D., THOMAS G. BENEDEK, M.D.Prophylaxis in patients receiving adrenal steroid therapyPericardial effusion and cor pulmonale in progressive systemic sclerosis (Scleroderma)DIFFUSE SCLERODERMA AND RAYNAUD'S DISEASE.VALVULAR DISEASE OF THE HEART IN SYSTEMIC SCLERODERMA.The Nature of Joint Involvement in Progressive Systemic Sclerosis (Diffuse Scleroderma) Clinical Study and Pathologic Examination of Synovium in Twenty-nine PatientsGERALD P. RODNAN, M.D.Focal sclerodermaMalabsorption in AcrosclerosisGastrointestinal abnormalities in the collagen diseasesFamilial Occurrence of Collagen Diseases: I. Progressive Systemic Sclerosis and Systemic Lupus ErythematosusFamilial Occurrence of Collagen Diseases: II. Progressive Systemic Sclerosis and DermatomyositisDie allgemeine Pathologie des BlutkreislaufesDas adrenocorticotrope Hormon (ACTH), die HormonederNebenniere(Cortison,Adrenalin) das Insulin, sowie die Hormone der Schilddrüse und NebenschilddrüseScleroderma (Progressive Systemic Sclerosis): A Case Involving Polyneuritis and Swelling of the Lymph NodesPrognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic SclerodermaRENAL INVOLVEMENT IN PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)*ROBERT J. LEVINE, M.D., BURIS R. BOSHELL, M.D.Myokarditis und weitere MyokardiopathienScleroderma (Progressive Systemic Sclerosis): A Case Involving Polyneuritis and Swelling of the Lymph NodesStudies on the Renal Changes IN Systemic Lupus ErythematodesDie Viscerale Manifestation der progressiven SklerodermieInterstitial pneumonia and its consequences in rheumatoid diseaseThe effect of collagenase on the fixed and unfixed skin lesions of morphœa: An electron-microscope studyRHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (TWELFTH RHEUMATISM REVIEW)* Part IICHARLEY J. SMYTH, M.D., F.A.C.P., JOSEPH J. BUNIM, M.D., F.A.C.P., WILLIAM S. CLARK, M.D., F.A.C.P., DARRELL C. CRAIN, M.D., F.A.C.P., FELIX E. DEMARTINI, M.D., IVAN F. DUFF, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P. (C), MAX M. MONTGOMERY, M.D., F.A.C.P., BERNARD M. NORCROSS, M.D., F.A.C.P., HOWARD F. POLLEY, MARIAN W. ROPES, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P.TREATMENT OF SCLERODERMA*CHRIS J. D. ZARAFONETIS, M.D., F.A.C.P.RENAL LESIONS IN SCLERODERMA : CLINICAL AND PATHOLOGICAL FEATURESDERMATOMYOSITIS WITH PULMONARY LESIONS*JEROME GOLDFISCHER, M.D., ELI H. RUBIN, M.D., F.A.C.P.Die Steroid-Therapie rheumatischer ErkrankungenThe electrocardiogram in scleroderma: Analysis of 60 cases and review of the literatureScleroderma with honeycomb lungs and bronchiolar carcinomaDiagnostic significance of the muscle biopsyElectrocardiograms of Ninety Patients with Acrosclerosis and Progressive Diffuse Sclerosis (Scleroderma)Generalized scleroderma associated with chronic ulcerative colitis"SPECIFIC" DISEASES SIMULATING "NONSPECIFIC" ULCERATIVE COLITIS (LYMPHOPATHIA VENEREUM, ACUTE VASCULITIS, SCLERODERMA AND SECONDARY AMYLOIDOSIS*MOSHE B. GOLDGRABER, M.D., JOSEPH B. KIRSNER, M.D., F.A.C.P.Renal involvement in progressive systemic sclerosis (generalized scleroderma)Gastrointestinal Scleroderma Simulating Chronic and Acute Intestinal ObstructionCollagen Disease of the Small BowelTRUE SCLERODERMA KIDNEYOBSERVATIONS ON THE USE OF PREDNISONE IN PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA)*GERALD P. RODNAN, ROGER L. BLACK, ALFRED JAY BOLLET, JOSEPH J. BUNIM, F.A.C.P.Die progressive SklerodermieCardiovascular Manifestations of Collagen DiseasesThe Medical Significance of Lenticular Opacities (Cataract) before the Age of FiftyCurrent pediatric references 1 November 1954Volume 41, Issue 5Page: 1003-1041KeywordsDermatomyositisHospital medicineLesionsSclerodermaSkin diseases ePublished: 1 December 2008 Issue Published: 1 November 1954 PDF downloadLoading ...